Greater Manchester Medicines Management Group

Greater Manchester Clinical Standards Board

NHS

News Summary

From this page you will be able to access a summary of additions or changes to the GMMMG website on a monthly basis

November 2018 

 

Pathways and Guidelines Development Subgroup (PaGDSG)

9.11.18

On behalf of the GMMMG Pathways and Guidelines Development Subgroup, Greater Manchester-wide diabetes pathways for Oral Antihyperglycaemics, Insulin Titration, and  Insulin Administration Timing, for Adults with Type 2 Diabetes are in development. We now seek comments on these drafts.  This consultation period is open until 21st December.

GMMMG

9.11.18

Following the Government’s announcement to reschedule certain cannabis-based products for medicinal use from 1 November 2018, NHS England has provided guidance to clinicians following the re-scheduling which sets out our expectations of what this regulatory change will mean in practice for clinicians working in the NHS and in private practice in England.

Information for patients and the public explaining what the changes mean will be available on the NHS website here.

 

Formulary and Managed Entry Subgroup (FMESG)

12.11.18

Following GM-wide consultation and approval by CSB, actions from the August meeting of FMESG have been published. Changes include:

  • Formulary was updated to reflect NICE technology appraisals of cenegermin, ocrelizumab, dupilumab, and ixekizumab
  • MHRA Drug Safety updates were added to formulary
  • Hyaluronate 0.4% eye drops single dose units were replaced with multi-dose bottles
  • The RAG status of megestrol was changed to GREEN (specialist initiation)
  • Ketamine oral solution was given a RAG status of RED
  • The grey list position of ferric maltol was updated to include use in people without GI disease.

The formulary and RAG list have been updated to reflect these changes.

9.11.18

The following actions were proposed at the October 2018 FMESG meeting and will be sent to CSB for pre-approval. We now seek comments on these proposals. This consultation period is open until 5pm on Friday 21st December 2018

<< Back

Line

TERMS AND CONDITIONS    |    CONTACT US    |    ABOUT US    |    ARCHIVE

RSS Feed
 
spacer